Literature DB >> 21860420

Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer.

M E Caldwell1, G M DeNicola, C P Martins, M A Jacobetz, A Maitra, R H Hruban, D A Tuveson.   

Abstract

During tumor initiation, oncogene-induced senescence (OIS) is proposed to limit the progression of preneoplasms to invasive carcinoma unless circumvented by the acquisition of certain tumor suppressor mutations. Using a variety of biomarkers, OIS has been previously reported in a wide range of human and murine precursor lesions, including the pancreas, lung, colon and skin. Here, we have characterized a panel of potential OIS biomarkers in human and murine pancreatic intraepithelial neoplasia (PanIN), and found that only senescence-associated β-galactosidase (SAβgal) activity is specifically enriched in these precursors, compared with pancreatic ductal adenocarcinoma (PDA). Indeed, many of the other proposed OIS biomarkers are detected in actively proliferating PanIN epithelium and in cells within the microenvironment. Surprisingly, acinar to ductal metaplasia (ADM), a distinct preneoplasm that is potentially a precursor for PanIN, also exhibits SAβgal activity and contains a higher content of p21 and p53 than PanIN. Therefore, SAβgal activity is the only biomarker that accurately identifies a small and heterogeneous population of non-proliferating premalignant cells in the pancreas, and the concomitant expression of p53 and p21 in ADM supports the possibility that PanIN and ADM each exhibit discrete senescence blocks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21860420      PMCID: PMC3397306          DOI: 10.1038/onc.2011.350

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

Review 1.  Progression model for pancreatic cancer.

Authors:  R H Hruban; M Goggins; J Parsons; S E Kern
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

2.  STRA13 expression and subcellular localisation in normal and tumour tissues: implications for use as a diagnostic and differentiation marker.

Authors:  A Ivanova; S-Y Liao; M I Lerman; S Ivanov; E J Stanbridge
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

3.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Authors:  C A Moskaluk; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

4.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.

Authors:  Carmen Guerra; Manuel Collado; Carolina Navas; Alberto J Schuhmacher; Isabel Hernández-Porras; Marta Cañamero; Manuel Rodriguez-Justo; Manuel Serrano; Mariano Barbacid
Journal:  Cancer Cell       Date:  2011-06-14       Impact factor: 31.743

5.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Tumour biology: senescence in premalignant tumours.

Authors:  Manuel Collado; Jesús Gil; Alejo Efeyan; Carmen Guerra; Alberto J Schuhmacher; Marta Barradas; Alberto Benguría; Angel Zaballos; Juana M Flores; Mariano Barbacid; David Beach; Manuel Serrano
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

7.  Oncogene-induced senescence as an initial barrier in lymphoma development.

Authors:  Melanie Braig; Soyoung Lee; Christoph Loddenkemper; Cornelia Rudolph; Antoine H F M Peters; Brigitte Schlegelberger; Harald Stein; Bernd Dörken; Thomas Jenuwein; Clemens A Schmitt
Journal:  Nature       Date:  2005-08-04       Impact factor: 49.962

Review 8.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

Authors:  R H Hruban; A D van Mansfeld; G J Offerhaus; D H van Weering; D C Allison; S N Goodman; T W Kensler; K K Bose; J L Cameron; J L Bos
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

10.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.

Authors:  S Srinivas; T Watanabe; C S Lin; C M William; Y Tanabe; T M Jessell; F Costantini
Journal:  BMC Dev Biol       Date:  2001-03-27       Impact factor: 1.978

View more
  36 in total

1.  Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.

Authors:  Tikvah K Hayes; Nicole F Neel; Chaoxin Hu; Prson Gautam; Melissa Chenard; Brian Long; Meraj Aziz; Michelle Kassner; Kirsten L Bryant; Mariaelena Pierobon; Raoud Marayati; Swapnil Kher; Samuel D George; Mai Xu; Andrea Wang-Gillam; Ahmed A Samatar; Anirban Maitra; Krister Wennerberg; Emanuel F Petricoin; Hongwei H Yin; Barry Nelkin; Adrienne D Cox; Jen Jen Yeh; Channing J Der
Journal:  Cancer Cell       Date:  2015-12-24       Impact factor: 31.743

2.  Loss of Wasl improves pancreatic cancer outcome.

Authors:  Ana Hidalgo-Sastre; Judit Desztics; Zahra Dantes; Katharina Schulte; Hilal Kabadayi Ensarioglu; Blessing Bassey-Archibong; Rupert Öllinger; Thomas Engleiter; Lyndsay Rayner; Henrik Einwächter; Juliet M Daniel; Ali Sameer Abdulghani Altaee; Katia Steiger; Marina Lesina; Roland Rad; Maximilian Reichert; Guido von Figura; Jens T Siveke; Roland M Schmid; Clara Lubeseder-Martellato
Journal:  JCI Insight       Date:  2020-05-21

3.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.

Authors:  Meredith A Collins; Filip Bednar; Yaqing Zhang; Jean-Christophe Brisset; Stefanie Galbán; Craig J Galbán; Sabita Rakshit; Karen S Flannagan; N Volkan Adsay; Marina Pasca di Magliano
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

4.  Increased expression of oncogene-induced senescence markers during cervical squamous cell cancer development.

Authors:  Yongsheng Zhang; Liangsheng Guo; Pengfei Xing; Yuanyuan Chen; Feng Li; Weipei Zhu; Xueguan Lu
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

5.  A high-content screening assay for small-molecule modulators of oncogene-induced senescence.

Authors:  Benjamin G Bitler; Lauren S Fink; Zhi Wei; Jeffrey R Peterson; Rugang Zhang
Journal:  J Biomol Screen       Date:  2013-06-03

6.  Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression.

Authors:  Maïté Rielland; David J Cantor; Richard Graveline; Cristina Hajdu; Lisa Mara; Beatriz de Diego Diaz; George Miller; Gregory David
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

7.  Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer.

Authors:  Constantinos P Zambirinis; Atsuo Ochi; Rocky Barilla; Stephanie Greco; Michael Deutsch; George Miller
Journal:  Cell Cycle       Date:  2013-04-02       Impact factor: 4.534

8.  Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.

Authors:  Marcus Ruscetti; John P Morris; Riccardo Mezzadra; James Russell; Josef Leibold; Paul B Romesser; Janelle Simon; Amanda Kulick; Yu-Jui Ho; Myles Fennell; Jinyang Li; Robert J Norgard; John E Wilkinson; Direna Alonso-Curbelo; Ramya Sridharan; Daniel A Heller; Elisa de Stanchina; Ben Z Stanger; Charles J Sherr; Scott W Lowe
Journal:  Cell       Date:  2020-03-31       Impact factor: 41.582

9.  p53 status determines the role of autophagy in pancreatic tumour development.

Authors:  Mathias T Rosenfeldt; Jim O'Prey; Jennifer P Morton; Colin Nixon; Gillian MacKay; Agata Mrowinska; Amy Au; Taranjit Singh Rai; Liang Zheng; Rachel Ridgway; Peter D Adams; Kurt I Anderson; Eyal Gottlieb; Owen J Sansom; Kevin M Ryan
Journal:  Nature       Date:  2013-12-04       Impact factor: 49.962

10.  RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis.

Authors:  Marina Lesina; Sonja Maria Wörmann; Jennifer Morton; Kalliope Nina Diakopoulos; Olga Korneeva; Margit Wimmer; Henrik Einwächter; Jan Sperveslage; Ihsan Ekin Demir; Timo Kehl; Dieter Saur; Bence Sipos; Mathias Heikenwälder; Jörg Manfred Steiner; Timothy Cragin Wang; Owen J Sansom; Roland Michael Schmid; Hana Algül
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.